Sfoglia per Autore
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?
2008-01-01 Galimberti, G; Conti, E; Zini, M; Piazza, F; Fenaroli, F; Isella, V; Facheris, M; Perlangeli, V; Antolini, L; De Filippi, F; Ferrarese, C
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients
2010-01-01 Conti, E; Galimberti, G; Tremolizzo, L; Masetto, A; Cereda, D; Zanchi, C; Piazza, F; Casati, M; Isella, V; Appollonio, I; Ferrarese, C
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients
2010-01-01 Conti, E; Galimberti, G; Piazza, F; Raggi, M; Ferrarese, C
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease
2011-01-01 Galimberti, G; Conti, E; Gregori, M; DA RE, F; Tironi, M; Masserini, M; Ferrarese, C
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid
2011-01-01 Tironi, M; Conti, E; Galimberti, G; Zoia, C; Tremolizzo, L; Ferrarese, C
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report
2011-01-01 DI FRANCESCO, J; Brioschi, M; Brighina, L; Ruffmann, C; Saracchi, E; Costantino, G; Galimberti, G; Conti, E; Curtò, N; Marzorati, L; Remida, P; Tagliavini, F; Savoiardo, M; Ferrarese, C
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis?
2011-06-30 DI FRANCESCO, J; Piazza, F; Conti, E; Tremolizzo, L; Savoiardo, M; Ferrarese, C
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease?
2012-01-01 DA RE, F; Conti, E; Galimberti, G; Gregori, M; Salvati, E; Tironi, M; Stefanoni, G; Rosa, M; Riva, C; Masserini, M; Ferrarese, C
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types
2012-01-01 Tremolizzo, L; Conti, E; Appollonio, I; Ferrarese, C
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients
2012-01-01 Tremolizzo, L; DI FRANCESCO, J; Rodriguez Menendez, V; Riva, C; Conti, E; Galimberti, G; Ruffmann, C; Ferrarese, C
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease
2012-01-01 Piazza, F; Galimberti, G; Conti, E; Isella, V; Perlangeli, M; Speranza, T; Borroni, B; Pogliani, E; Padovani, A; Ferrarese, C
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid
2012-01-01 Tremolizzo, L; Sala, G; Conti, E; RODRIGUEZ MENENDEZ, V; Lunetta, C; Fogli, A; Penco, S; Ferrarese, C; Corbo, M
Whole-blood global DNA methylation and phenotypic variability in ALS
2012-01-01 Tremolizzo, L; Conti, E; Sala, G; Cecchi, M; Airoldi, L; Pastorelli, R; Messina, P; Pupillo, E; Beghi, E; Ferrarese, C; Eurals,
Myocyte enhancer factor-2D expression in ALS lymphomonocytes
2012-01-01 Tremolizzo, L; Sala, G; Conti, E; Arosio, A; RODRIGUEZ MENENDEZ, V; Ferrarese, C
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors
2012-01-01 Tironi, M; Conti, E; Santarone, M; Galimberti, G; Zoia, C; Tremolizzo, L; Ferrarese, C
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa.
2013-01-01 Conti, E; Tremolizzo, L; Bomba, M; Uccellini, O; Rossi, M; Raggi, M; Neri, F; Ferrarese, C; Nacinovich, R
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study
2013-01-01 Tremolizzo, L; Conti, E; Santarone, M; Tironi, M; Zoia, C; Appollonio, I; Ferrarese, C
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study
2013-01-01 Conti, E; Tremolizzo, L; Santarone, M; Tironi, M; Zoia, C; Appollonio, I; Ferrarese, C
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease
2013-01-01 Tremolizzo, L; Conti, E; Zoia, C; Rizzo, C; GAMBACORTI PASSERINI, C; Weksler, M; Weksler, B; Ferrarese, C
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor
2013-01-01 Tremolizzo, L; Conti, E; Zoia, C; Rizzo, C; GAMBACORTI PASSERINI, C; Weksler, M; Weksler, B; Ferrarese, C
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile